(Q44634844)

4 December 2017

title

Is 3-mm less drowsiness important? (English)

1 reference

4 December 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14582809

26 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)61676-6

26 March 2024

author name string

Jay M. Portnoy

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14582809

26 March 2024

Stephen D. Simon

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14582809

26 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14582809

26 March 2024

publication date

1 October 2003

1 reference

full work available at URL

4 December 2017

https://api.elsevier.com/content/article/PII:S1081120610616766?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)61676-6

https://api.elsevier.com/content/article/PII:S1081120610616766?httpAccept=text/plain

26 March 2024

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)61676-6

Annals of Allergy, Asthma & Immunology

26 March 2024

published in

1 reference

4 December 2017

volume

91

1 reference

4 December 2017

issue

4

1 reference

4 December 2017

page(s)

324-325

1 reference

Efficacy and safety of clemastine-pseudoephedrine-acetaminophen versus pseudoephedrine-acetaminophen in the treatment of seasonal allergic rhinitis in a 1-day, placebo-controlled park study

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961676-6

7 January 2021

Effects of Fexofenadine, Diphenhydramine, and Alcohol on Driving Performance: A Randomized, Placebo-Controlled Trial in the Iowa Driving Simulator

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961676-6

7 January 2021

Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961676-6

7 January 2021

Clinical pharmacology of H1-antihistamines in the skin

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961676-6

7 January 2021

Fexofenadine is efficacious and safe in children (aged 6-11 years) with seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961676-6

7 January 2021

Quality of life in adults and children with allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961676-6

7 January 2021

Use of ultramolecular potencies of allergen to treat asthmatic people allergic to house dust mite: double blind randomised controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961676-6

7 January 2021

Immediate and long term effects of weight reduction in obese people with asthma: randomised controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961676-6

7 January 2021

Randomised controlled trial of homoeopathy versus placebo in perennial allergic rhinitis with overview of four trial series

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961676-6

7 January 2021

Determining the minimum clinically significant difference in visual analog pain score for children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961676-6

7 January 2021

The real-world risk of taking sedating antihistamines

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961676-6

7 January 2021

Conflict of interest in the debate over calcium-channel antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961676-6

7 January 2021

The publication of sponsored symposiums in medical journals

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961676-6

7 January 2021

Editorials and conflicts of interest

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2961676-6

7 January 2021

How well is the clinical importance of study results reported? An assessment of randomized controlled trials

12

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)61676-6

Competing interests. Problem is greater than editorial indicates

26 March 2024

15

1 reference

https://api.crossref.org/works/10.1016/S1081-1206(10)61676-6

26 March 2024

Identifiers

1 reference

4 December 2017

1 reference